1. Stocks
    2. /
  2. Telix Pharmaceuticals (ASX: TLX)
    3. /

Telix Pharmaceuticals (ASX: TLX) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Telix Pharmaceuticals Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Telix Pharmaceuticals (ASX: TLX)
    Latest News

    A young family with two kids smiling as they look out the window of an apartment they just bought
    Share Market News

    ASX shares vs. property: The opportunities in 2024

    | Bronwyn Allen

    Four property markets are 'in favour of buyers' while mining stocks look hot for 2024, say these experts.

    Read more »

    Three health professionals at a hospital smile for the camera.
    Healthcare Shares

    3 ASX healthcare stocks you'll be glad you bought when the bull market starts

    | Tony Yoo

    The health sector has been out of favour for a couple of years, but that could all change once interest…

    Read more »

    2 fingers with happy faces next to finger drawn with a sad face.
    Investing Strategies

    2 ASX shares to buy this month… and one I'd avoid

    | Tony Yoo

    The Australian share market is so concentrated in two industries that stock picking can be better for diversification.

    Read more »

    Two happy scientists analysing test results.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a great day to be invested today...

    Read more »

    a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
    Healthcare Shares

    2 ASX healthcare shares I think are overdue for a big rally

    | Tony Yoo

    I think these early stage drug companies could have a barnstorming 2024.

    Read more »

    A diverse group of people form a circle at a park and raise their arms together.
    Share Market News

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a happy end to November for ASX investors this Thursday.

    Read more »

    A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
    Share Market News

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    The ASX 200 closed the trading week on a positive note today.

    Read more »

    A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
    Growth Shares

    Could buying these ASX shares at $9 now be like investing in Tesla in 2010?

    | Tony Yoo

    This Melbourne company is making big strides in its field and has returned a phenomenal 67% each year for its…

    Read more »

    A couple are happy sitting on their yacht.
    Investing Strategies

    Invest in these 2 ASX shares for a real shot at $1 million

    | Tony Yoo

    Getting to seven figures is possible, but only if you give it a try. Check out these stocks that could…

    Read more »

    A bored woman looking at her computer, it's bad news.
    Share Market News

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    Do you own any of today's top-best performing ASX 200 shares?

    Read more »

    Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    The ASX 200 slipped back into loss territory this Wednesday.

    Read more »

    Seven people look for bargains to buy at a yard sale.
    Cheap Shares

    7 oversold ASX shares to buy in November 2023

    | Motley Fool Staff

    With great market falls often come great buying opportunities...

    Read more »

    Frequently Asked Questions

    No, Telix does not pay dividends at this time. 

    Telix Pharmaceuticals Ltd listed on the ASX on 15 November 2017.

    TLX ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Telix Pharmaceuticals

    Telix Pharmaceuticals Ltd (ASX: TLX) is a commercial-stage biopharmaceutical company focused on the ongoing development of diagnostic and therapeutic ('theranostic') products using targeted radiation. This process treats cancerous or diseased cells, an alternative approach to many cancer therapies which also attack healthy tissue at the same time.

    Telix has received global regulatory approvals from the Australian Therapeutic Goods Administration (TGA), the US Food and Drug Administration (FDA), and Health Canada for its prostate cancer imaging agent Illuccix. It is working to get Illuccix approved for sale in the UK and Europe. 

    The company also has more than 20 clinical trials underway worldwide. Telix's research and development is focused on prostate, renal (kidney), glioblastoma (brain), and hematologic (bone marrow conditioning) cancers, as well as rare diseases. The company is headquartered in Australia with offices in Belgium, Japan, Switzerland, and the United States. 

    Profile

    since

    Note